By Bryan Koenig ( December 2, 2019, 6:49 PM EST) -- United Kingdom antitrust enforcers in November cleared Salesforce's nearly $16 billion purchase of an analytics platform, Danaher tried to win the European Commission's blessing for its $21.4 billion proposed purchase of General Electric's biopharma business, and the Federal Trade Commission signed off on a drug divestiture to clear Bristol-Myers Squibb's $74 billion purchase of Celgene....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.